As of 3/3, vaccines are available to MSK patients age 18 and over who live in New York State and who were treated for cancer at MSK on or after 1/1/18. For more info, and if you live in NJ: Read more
My current research is focused on adaptive resistance mechanism of KRAS mutant cancer cells, especially to KRASG12C-specific inhibitor. I aim to contribute to improving the outcome of patients with KRAS mutant cancer.
